https://www.selleckchem.com/pr....oducts/finerenone.ht
Opioid misuse risk may be similar in individuals with chronic cancer and noncancer pain. However, risk screening is not uniformly used for patients with cancer, so its prevalence is unknown. The primary aim of this study was to estimate the level of risk for opioid misuse among patients with cancer. Secondary aims were to compare opioid misuse risk across cancer types and specialties and to explore psychosocial factors that may contribute to opioid misuse risk. Clinicians were trained to administer the Opioid Risk Tool during ambulat
Curtir
Comentario
Compartilhar
